[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1999

High Prevalence of Cutaneous Reactions to Interferon Alfa Plus Ribavirin Combination Therapy in Patients With Chronic Hepatitis C Virus

Author Affiliations

Not Available

Arch Dermatol. 1999;135(8):1000-1001. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-8-dlt0899

Interferon alfa plus ribavirin combination therapy for patients with chronic hepatitis C virus (HCV) may be a better treatment option than either drug alone given its potential benefit and reduced incremental toxicity profile.1 The aim of this study is to describe clinical and histological features of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with HCV.